Topic · page 12 of 12

Across rheumatic diseases

Only studies that genuinely span several rheumatic diseases, such as drug safety and pharmacovigilance, infection, vaccination and comorbidity (cardiovascular, cancer, mental health) across diseases, and health services and quality of care across diseases. Never a fallback for an article that is hard to place

Briefs 441–474 of 474 placed here, newest publication first

Briefs in Across rheumatic diseases

Newest publication first

Lancet Rheumatol16 Nov 2022
Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study
Cohort study
Semin Arthritis Rheum13 Nov 2022
Association of vocational interventions and work-related factors with disease and work outcomes in people with RMDs: A systematic review
Meta-analysis
Arthritis Care Res (Hoboken)13 Nov 2022
Extent of and Reasons for Discontinuation and Nonpublication of Interventional Trials on Connective Tissue Diseases: An Observational Study
Cohort study
Semin Arthritis Rheum12 Nov 2022
Cognitive impairment in the immune-mediated inflammatory diseases compared with age-matched controls: Systematic review and meta-regression
Meta-analysis
Arthritis Rheumatol8 Nov 2022
American College of Rheumatology Guidance for COVID ‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5
Guideline or statement
Ann Rheum Dis3 Nov 2022
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases
Guideline or statement
Scand J Rheumatol31 Oct 2022
Reduced prescription of TNF-inhibitors in chronic arthritis based on therapeutic drug monitoring: A randomized controlled trial
Randomized controlled trial
Semin Arthritis Rheum26 Oct 2022
Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study
Cohort study
Arthritis Care Res (Hoboken)21 Oct 2022
Assessing the Severity of COVID‐19 Lung Injury in Rheumatic Diseases Versus the General Population Using Deep Learning–Derived Chest Radiograph Scores
Cohort study
Rheumatology (Oxford)17 Oct 2022
Humoral and cellular immunity in patients with rare autoimmune rheumatic diseases following SARS-CoV-2 vaccination
Cohort study
Arthritis Care Res (Hoboken)12 Oct 2022
Association of Area‐Level Heat and Social Vulnerability With Recurrent Hospitalizations Among Individuals With Rheumatic Conditions
Cohort study
Arthritis Care Res (Hoboken)5 Oct 2022
Ambulatory Medication Safety: Vaccination and Laboratory Screening for Patients Receiving Immunomodulatory Therapies
Cohort study
Scand J Rheumatol29 Sep 2022
Impact of triage by a rheumatologist on appropriateness of referrals from primary to secondary care: a cluster randomized trial
Randomized controlled trial
Rheumatology (Oxford)19 Sep 2022
Obstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination status
Cohort study
Ann Rheum Dis15 Sep 2022
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls
Research article
Ann Rheum Dis15 Sep 2022
2021 EULAR points to consider to support people with rheumatic and musculoskeletal diseases to participate in healthy and sustainable paid work
Guideline or statement
Arthritis Care Res (Hoboken)14 Sep 2022
How Does Job Insecurity and Workplace Activity Limitations Relate to Rheumatic Disease Symptom Trajectories in Young Adulthood? A Longitudinal Study
Cohort study
Rheumatology (Oxford)7 Sep 2022
COVID-19 vaccine hesitancy in inflammatory arthritis patients: serial surveys from a large longitudinal national Australian cohort
Cohort study
Rheumatology (Oxford)25 Aug 2022
Physical activity assessment with wearable devices in rheumatic diseases: a systematic review and meta-analysis
Meta-analysis
Rheumatology (Oxford)11 Aug 2022
Sexual dysfunction in women with systemic autoimmune rheumatic disorders: a systematic review and meta-analysis
Meta-analysis
Ann Rheum Dis11 Aug 2022
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update
Guideline or statement
Rheumatology (Oxford)3 Aug 2022
Different COVID-19 outcomes among systemic rheumatic diseases: a nation-wide cohort study
Cohort study
Scand J Rheumatol14 Jul 2022
Presence of SARS-CoV-2 antibodies in patients with COVID-19 like symptoms from the IENIMINI cohort
Cohort study
Clin Exp Rheumatol10 Jul 2022
The predictive value of antinuclear antibodies in patients with suspected connective tissue disease for the development of connective tissue diseases
Cohort study
Scand J Rheumatol12 May 2022
Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in Scotland
Case-control study
Ann Rheum Dis12 May 2022
EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases
Guideline or statement
Ann Rheum Dis8 Mar 2022
2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases
Guideline or statement
Scand J Rheumatol2 Mar 2022
Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a randomized controlled trial
Randomized controlled trial
Clin Exp Rheumatol18 Feb 2022
Medical cannabis use by rheumatology patients in routine clinical care: results from The Ontario Best Practices Research Initiative
Cross-sectional study
Clin Exp Rheumatol21 Jan 2022
Effectiveness of non-medical switch from adalimumab bio-originator to SB5 biosimilar and from ABP501 adalimumab biosimilar to SB5 biosimilar in patients with chronic inflammatory arthropathies: a monocentric observational study
Cohort study
Scand J Rheumatol20 Jan 2022
Antibody response in patients with autoimmune inflammatory rheumatic disease after pneumococcal polysaccharide prime vaccination or revaccination
Cohort study
Clin Exp Rheumatol15 Jan 2022
Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs
Cohort study
Scand J Rheumatol11 Jan 2022
Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents
Cross-sectional study
Clin Exp Rheumatol28 Nov 2021
Long-term evaluation of pulmonary function and survival of patients with interstitial pneumonia with autoimmune features
Cohort study

All 474 Briefs in ExploreShowing Briefs 441–474 of 474, newest first